Nemo II inhibitors refer to a category of chemical compounds specifically designed to target and modulate the activity of a protein known as Nemo-like kinase II, often abbreviated as Nemo II. Nemo-like kinases are a subgroup of protein kinases within the serine/threonine protein kinase family, and they are involved in various cellular processes, including cell signaling, gene expression regulation, and cell cycle control. The precise role of Nemo II and its inhibitors in cellular processes is an area of ongoing research in molecular biology and cell biology.
These inhibitors are typically small molecules or compounds designed to interact with Nemo II, influencing its kinase activity or its interactions with specific substrates, co-factors, or regulatory proteins. By doing so, Nemo II inhibitors may impact cellular signaling pathways and molecular processes that are dependent on the activity of Nemo II. Research into Nemo II inhibitors is vital for gaining insights into the functions and regulatory mechanisms of this kinase and for understanding its role in fundamental cellular processes. Additionally, this research may contribute to a deeper understanding of cell signaling networks and implications in cellular physiology.
SEE ALSO...
Items 11 to 11 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imatinib mesylate | 220127-57-1 | sc-202180 sc-202180A | 25 mg 100 mg | $45.00 $111.00 | 61 | |
A tyrosine-kinase inhibitor known to target BCR-ABL, c-KIT, and PDGFR, and potentially could affect signaling pathways that have a regulatory effect on NLK. | ||||||